These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 14508365

  • 1. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD, Ghent C, Grant D, Horbay GL, McDougal J, David Colby W.
    Transplantation; 2003 Sep 27; 76(6):977-83. PubMed ID: 14508365
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
    Nucci M, Biasoli I, Akiti T, Silveira F, Solza C, Barreiros G, Spector N, Derossi A, Pulcheri W.
    Clin Infect Dis; 2000 Feb 27; 30(2):300-5. PubMed ID: 10671332
    [Abstract] [Full Text] [Related]

  • 3. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
    Biancofiore G, Bindi ML, Baldassarri R, Romanelli AM, Catalano G, Filipponi F, Vagelli A, Mosca F.
    Transpl Int; 2002 Jul 27; 15(7):341-7. PubMed ID: 12122510
    [Abstract] [Full Text] [Related]

  • 4. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.
    Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE.
    Clin Infect Dis; 2002 Jan 15; 34(2):277-84. PubMed ID: 11740718
    [Abstract] [Full Text] [Related]

  • 5. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    McKinsey DS, Wheat LJ, Cloud GA, Pierce M, Black JR, Bamberger DM, Goldman M, Thomas CJ, Gutsch HM, Moskovitz B, Dismukes WE, Kauffman CA.
    Clin Infect Dis; 1999 May 15; 28(5):1049-56. PubMed ID: 10452633
    [Abstract] [Full Text] [Related]

  • 6. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany.
    J Antimicrob Chemother; 2006 Feb 15; 57(2):317-25. PubMed ID: 16339606
    [Abstract] [Full Text] [Related]

  • 7. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ, Böhme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA.
    J Infect; 2007 Nov 15; 55(5):445-9. PubMed ID: 17822770
    [Abstract] [Full Text] [Related]

  • 8. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto.
    Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, Girmenia C, Barbabietola G, Pagańo L, Leoni P, Specchia G, Caiozzo A, Raimondi R, Mandelli F.
    Clin Infect Dis; 1999 Feb 15; 28(2):250-5. PubMed ID: 10064240
    [Abstract] [Full Text] [Related]

  • 9. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP, Kurup A, Goh YT, Fook-Chong SM, Tan PH.
    Am J Hematol; 2002 Dec 15; 71(4):260-7. PubMed ID: 12447954
    [Abstract] [Full Text] [Related]

  • 10. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF, Pontón C, Bustamante M, Otero E, Martínez J, Tomé S, Conde R, Segade FR, Delgado M, Brage A, Galbán C, Varo E.
    Transplant Proc; 2005 Nov 15; 37(9):3965-7. PubMed ID: 16386598
    [Abstract] [Full Text] [Related]

  • 11. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian H.
    Cancer; 2003 Jan 15; 97(2):450-6. PubMed ID: 12518369
    [Abstract] [Full Text] [Related]

  • 12. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC.
    Mycoses; 1999 Jan 15; 42 Suppl 2():121-4. PubMed ID: 10865918
    [Abstract] [Full Text] [Related]

  • 13. Itraconazole to prevent fungal infections in chronic granulomatous disease.
    Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, Eisenstein EM, Turner ML, DeCarlo ES, Starling JM, Holland SM.
    N Engl J Med; 2003 Jun 12; 348(24):2416-22. PubMed ID: 12802027
    [Abstract] [Full Text] [Related]

  • 14. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L, Kuehlke O, Beilken A, Sander A, Linderkamp C, Schmid H, Seidemann K, Sykora KW, Schuster FR, Welte K.
    Pediatr Transplant; 2007 May 12; 11(3):261-6. PubMed ID: 17430480
    [Abstract] [Full Text] [Related]

  • 15. [The impact of itraconazole versus fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation].
    Cai CJ, Yi SH, Guo Y, Li MR, Yi HM, Yang Y, Lu MQ, Chen GH.
    Zhonghua Nei Ke Za Zhi; 2007 Nov 12; 46(11):911-3. PubMed ID: 18261273
    [Abstract] [Full Text] [Related]

  • 16. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
    Tollemar J, Ringdén O, Andersson S, Sundberg B, Ljungman P, Tydén G.
    Bone Marrow Transplant; 1993 Dec 12; 12(6):577-82. PubMed ID: 8136741
    [Abstract] [Full Text] [Related]

  • 17. Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders.
    Foot AB, Veys PA, Gibson BE.
    Bone Marrow Transplant; 1999 Nov 12; 24(10):1089-93. PubMed ID: 10578159
    [Abstract] [Full Text] [Related]

  • 18. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
    Kelsey SM, Goldman JM, McCann S, Newland AC, Scarffe JH, Oppenheim BA, Mufti GJ.
    Bone Marrow Transplant; 1999 Jan 12; 23(2):163-8. PubMed ID: 10197802
    [Abstract] [Full Text] [Related]

  • 19. Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study.
    Arrieta AC, Shea K, Dhar V, Cleary JP, Kukreja S, Morris M, Vargas-Shiraishi OM, Ashouri N, Singh J.
    Clin Ther; 2010 Feb 12; 32(2):265-71. PubMed ID: 20206784
    [Abstract] [Full Text] [Related]

  • 20. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus.
    Supparatpinyo K, Perriens J, Nelson KE, Sirisanthana T.
    N Engl J Med; 1998 Dec 10; 339(24):1739-43. PubMed ID: 9845708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.